CoChat
Sign Up
Cited by 121SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice

Open access
Huang, Kun, Zhang, Yufei, Hui, Xianfeng, Zhao, Ya, Gong, Wenxiao, Wang, Ting, Zhang, Shaoran, Yang, Yong, Deng, Fei, Zhang, Qiang, Chen, Xi, Yang, Ying, Sun, Xiaomei, Chen, Huanchun, Tao, Yizhi J., Zou, Zhong, Jin, Meilin·2021·EBioMedicine
DOI 10.1016/j.ebiom.2021.103381PMC PMC8118724
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: An ideal animal model to study SARS-coronavirus 2 (SARS-CoV-2) pathogenesis and evaluate therapies and vaccines should reproduce SARS-CoV-2 infection and recapitulate lung disease like those seen in humans. The angiotensin-converting enzyme 2 (ACE2) is a functional receptor for SARS-CoV-2, but mice are resistant to the infection because their ACE2 is incompatible with the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein . METHODS: SARS-CoV-2 was passaged in BALB/c mice to obtain mouse-adapted virus strain. Complete genome deep sequencing of different generations of viruses was performed to characterize the dynamics of the adaptive mutations in SARS-CoV-2. Indirect immunofluorescence analysis and Biolayer interferometry experiments determined the binding affinity of mouse-adapted SARS-CoV-2 WBP-1 RBD to mouse ACE2 and human ACE2. Finally, we tested whether TLR7/8 agonist Resiquimod (R848) could also inhibit the replication of WBP-1 in the mouse model. FINDINGS: The mouse-adapted strain WBP-1 showed increased infectivity in BALB/c mice and led to severe interstitial pneumonia. We characterized the dynamics of the adaptive mutations in SARS-CoV-2 and demonstrated that Q493K and Q498H in RBD significantly increased its binding affinity towards mouse ACE2. Additionally, the study tentatively found that the TLR7/8 agonist Resiquimod was able to protect mice against WBP-1 challenge. Therefore, this mouse-adapted strain is a useful tool to investigate COVID-19 and develop new therapies. INTERPRETATION: We found for the first time that the Q493K and Q498H mutations in the RBD of WBP-1 enhanced its interactive affinities with mACE2. The mouse-adapted SARS-CoV-2 provides a valuable tool for the evaluation of novel antiviral and vaccine strategies. This study also tentatively verified the antiviral activity of TLR7/8 agonist Resiquimod against SARS-CoV-2 in vitro and in vivo. FUNDING: This research was funded by the National Key Research and Development Program of China (2020YFC0845600) and Emergency Science and Technology Project of Hubei Province (2020FCA046) and Robert A. Welch Foundation (C-1565).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2021.103381

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Generation of mouse-adapted SARS-CoV-2 WBP-1. Wild type (WT) Wuhan-Hu-1 was passaged in old and young mice to obtain WBP-1 that was adapted to cause respiratory disease in mice. (a) Hematoxylin and eosin (H&E) staining of lung sections from mice infected with virus obtained through different passages (P2, P5, P8, P11) of SARS-CoV-2. Scale bars, 100 μm. (b) Viral copies were detected through qRT-PCR at three days post infection (dpi) in the lungs. (c) Five clonal isolates were obtained from the P11 virus pool by three rounds of plaque purification in Vero cells. The strain #2 that showed a high mortality rate in mice was defined as WBP-1. (d) Location of the mutations and deletion in the genome of WBP-1. WBP-1 obtained five synonymous (purple triangles), five nonsynonymous (red triangles), and a 740 bp deletion (black line). (e) Mutational frequency during SARS-CoV-2 experimental passage in pooled mouse groups. Single nucleotide variants are represented along the genome for the mice of passage 5, passage 8, passage 11 and WBP-1 virus.
Fig. 1 Generation of mouse-adapted SARS-CoV-2 WBP-1. Wild type (WT) Wuhan-Hu-1 was passaged in old and young mice to obtain WBP-1 that was adapted to cause respiratory disease in mice. (a) Hematoxylin and eosin (H&E) staining of lung sections from mice infected with virus obtained through different passages (P2, P5, P8, P11) of SARS-CoV-2. Scale bars, 100 μm. (b) Viral copies were detected through qRT-PCR at three days post infection (dpi) in the lungs. (c) Five clonal isolates were obtained from the P11 virus pool by three rounds of plaque purification in Vero cells. The strain #2 that showed a high mortality rate in mice was defined as WBP-1. (d) Location of the mutations and deletion in the genome of WBP-1. WBP-1 obtained five synonymous (purple triangles), five nonsynonymous (red triangles), and a 740 bp deletion (black line). (e) Mutational frequency during SARS-CoV-2 experimental passage in pooled mouse groups. Single nucleotide variants are represented along the genome for the mice of passage 5, passage 8, passage 11 and WBP-1 virus.CC BY-NC-ND · PubMed Central
Fig. 2 Characterization of mouse-adapted SARS-CoV-2 WBP-1 in mice. (a, b) Groups of mice (n = 5) were intranasally infected with 10-fold serial dilutions of WBP-1 virus. The infected mice were observed for weight loss and survival for 10 dpi. (c- f) Mice (n = 6) were intranasally infected with 2 LD50 of the WBP-1 virus and mice in the control group were mock-infected with DMEM. (c) Viral RNA copies were determined through qRT-PCR at 3 and 5 dpi in the heart, liver, lung, kidney, brain, intestine, trachea, turbinate, and spleen of WBP-1. (d) Viral titers in the lung were determined through plaque assays. (e) Cytokine (IL1β, TNFα, MCP1, and IL10) mRNA levels in the lung were evaluated at 3 and 5 dpi. Statistical significance was analyzed by unpaired Student's t tests. *p < 0.05; **p < 0.01; ***p < 0.001 ****p < 0.0001. (f) Hematoxylin and eosin (H&E) staining of lung sections from mice infected Mouse-adapted WBP-1 virus (Exfoliated necrotic cells, black arrow; Mononuclear lymphocytes, green arrow; Inflammatory exudate, red arrow; Vascular thrombosis, blue arrow). Scale bars (black), 100 μm. Scale bars (green), 50 μm. (g) Immunohistochemical detection of viral antigen using anti-Spike protein Rabbit monoclonal antibody in bronchi and alveoli. Scale bars (black), 100 μm. Scale bars (green), 50 μm.
Fig. 2 Characterization of mouse-adapted SARS-CoV-2 WBP-1 in mice. (a, b) Groups of mice (n = 5) were intranasally infected with 10-fold serial dilutions of WBP-1 virus. The infected mice were observed for weight loss and survival for 10 dpi. (c- f) Mice (n = 6) were intranasally infected with 2 LD50 of the WBP-1 virus and mice in the control group were mock-infected with DMEM. (c) Viral RNA copies were determined through qRT-PCR at 3 and 5 dpi in the heart, liver, lung, kidney, brain, intestine, trachea, turbinate, and spleen of WBP-1. (d) Viral titers in the lung were determined through plaque assays. (e) Cytokine (IL1β, TNFα, MCP1, and IL10) mRNA levels in the lung were evaluated at 3 and 5 dpi. Statistical significance was analyzed by unpaired Student's t tests. *p < 0.05; **p < 0.01; ***p < 0.001 ****p < 0.0001. (f) Hematoxylin and eosin (H&E) staining of lung sections from mice infected Mouse-adapted WBP-1 virus (Exfoliated necrotic cells, black arrow; Mononuclear lymphocytes, green arrow; Inflammatory exudate, red arrow; Vascular thrombosis, blue arrow). Scale bars (black), 100 μm. Scale bars (green), 50 μm. (g) Immunohistochemical detection of viral antigen using anti-Spike protein Rabbit monoclonal antibody in bronchi and alveoli. Scale bars (black), 100 μm. Scale bars (green), 50 μm.CC BY-NC-ND · PubMed Central
Fig. 3 WBP-1 virus using mouse ACE2 to gain access to cells was determined by immunofluorescence. Hela cells with transfection of empty vector (Flag), hACE2, or mACE2 plasmids were infected with WT Wuhan-Hu-1 or mouse-adapted WBP-1. ACE2 expression was detcted using rabbit anti-ACE2 IgG followed by CoraLite594-conjugated goat anti-rabbit IgG (H+L). SARS-CoV-2 nucleocapsid expression was detected using mouse anti-NP IgG followed by CoraLite488-conjugated Affinipure goat anti-mouse IgG(H+L). Nuclei were stained with DAPI. Scale bars, 200 μm.
Fig. 3 WBP-1 virus using mouse ACE2 to gain access to cells was determined by immunofluorescence. Hela cells with transfection of empty vector (Flag), hACE2, or mACE2 plasmids were infected with WT Wuhan-Hu-1 or mouse-adapted WBP-1. ACE2 expression was detcted using rabbit anti-ACE2 IgG followed by CoraLite594-conjugated goat anti-rabbit IgG (H+L). SARS-CoV-2 nucleocapsid expression was detected using mouse anti-NP IgG followed by CoraLite488-conjugated Affinipure goat anti-mouse IgG(H+L). Nuclei were stained with DAPI. Scale bars, 200 μm.CC BY-NC-ND · PubMed Central
Fig. 4 Mouse-adapted WBP-1 virus RBD enhance interactive affinities with mACE2. (a-d) Modelling of SARS-CoV-2 RBD–ACE2 interface. (a) Wuhan-Hu-1 RBD interacts with of human ACE2. (b) WBP-1 RBD (Q493K/Q498H-RBD) interacts human ACE2. (c) Modelling of Wuhan-Hu-1 RBD and mouse ACE2. (d) Modelling of WBP-1 RBD (Q493K/Q498H-RBD) shows interaction with mouse ACE2. (e-l) The binding affinities of the RBD of WBP-1 and mACE2 or hACE2 were determined through BLI experiments. The sensors were dipped in mACE2-hFC and functionalized sensorgrams captured upon incubation of Q493K-RBD (e), Q498H-RBD (f), Q493K/Q498H-RBD (g), and WT-RBD (h) at 6.25 (black), 12.5 (blue), 25 (green), and 50 nM (red). The sensors were dipped in hACE2-hFC and functionalized sensorgrams captured upon incubation of Q493K-RBD (i), Q498H-RBD (j), Q493K/Q498H-RBD (k), and WT-RBD (l) at 50 (black), 100 (blue), 200 (green), and 400 nM (red).
Fig. 4 Mouse-adapted WBP-1 virus RBD enhance interactive affinities with mACE2. (a-d) Modelling of SARS-CoV-2 RBD–ACE2 interface. (a) Wuhan-Hu-1 RBD interacts with of human ACE2. (b) WBP-1 RBD (Q493K/Q498H-RBD) interacts human ACE2. (c) Modelling of Wuhan-Hu-1 RBD and mouse ACE2. (d) Modelling of WBP-1 RBD (Q493K/Q498H-RBD) shows interaction with mouse ACE2. (e-l) The binding affinities of the RBD of WBP-1 and mACE2 or hACE2 were determined through BLI experiments. The sensors were dipped in mACE2-hFC and functionalized sensorgrams captured upon incubation of Q493K-RBD (e), Q498H-RBD (f), Q493K/Q498H-RBD (g), and WT-RBD (h) at 6.25 (black), 12.5 (blue), 25 (green), and 50 nM (red). The sensors were dipped in hACE2-hFC and functionalized sensorgrams captured upon incubation of Q493K-RBD (i), Q498H-RBD (j), Q493K/Q498H-RBD (k), and WT-RBD (l) at 50 (black), 100 (blue), 200 (green), and 400 nM (red).CC BY-NC-ND · PubMed Central
Fig. 5 R848 inhibits SARS-CoV-2 in vitro and in vivo. (a) Caco2 cells were treated with R848 (0-20 μM) for 24 h before infection with viruses at a multiplicity of infection (MOI) of 1. Infected cells were further incubated in the R848. Samples were collected at 48 and 72 h post infection (hpi) and viral titers were determined using plaque assays. (b-e) (n = 10) Mice were intraperitoneally injected with R848 after immediately intranasal infection with the WBP-1 virus. Infected mice were further treated with the R848 or PBS once a day for four consecutive days. Mice were monitored for weight loss (b) and survival (c) for 10 days. (d) Viral loads in mice lung, trachea and turbinate were determined at 5 dpi. (e) Hematoxylin and eosin (H&E) staining of lung sections from PBS or R848 treated mice. Scale bars (black), 100 μm. Scale bars (green), 50 μm. (a) and (d), Log transformed data analyzed by Two-way ANOVA followed by Sidak's multiple comparisons. The line represents the mean and error bars represent standard deviation. *p < 0.05; **p < 0.01; ***p < 0.001 ****p < 0.0001.
Fig. 5 R848 inhibits SARS-CoV-2 in vitro and in vivo. (a) Caco2 cells were treated with R848 (0-20 μM) for 24 h before infection with viruses at a multiplicity of infection (MOI) of 1. Infected cells were further incubated in the R848. Samples were collected at 48 and 72 h post infection (hpi) and viral titers were determined using plaque assays. (b-e) (n = 10) Mice were intraperitoneally injected with R848 after immediately intranasal infection with the WBP-1 virus. Infected mice were further treated with the R848 or PBS once a day for four consecutive days. Mice were monitored for weight loss (b) and survival (c) for 10 days. (d) Viral loads in mice lung, trachea and turbinate were determined at 5 dpi. (e) Hematoxylin and eosin (H&E) staining of lung sections from PBS or R848 treated mice. Scale bars (black), 100 μm. Scale bars (green), 50 μm. (a) and (d), Log transformed data analyzed by Two-way ANOVA followed by Sidak's multiple comparisons. The line represents the mean and error bars represent standard deviation. *p < 0.05; **p < 0.01; ***p < 0.001 ****p < 0.0001.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Dinnon, 2020, A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures, Nature, 586, 560, 10.1038/s41586-020-2708-8 · DOI · Paper page
  2. Zhao, 2012, Intranasal treatment with poly(I*C) protects aged mice from lethal respiratory virus infections, J Virol, 86, 11416, 10.1128/JVI.01410-12 · DOI

Cited by

Sorted by citations

See all 121

Related

See all

Metadata

Authors
Huang, K., Zhang, Y., Hui, X., Zhao, Y., Gong, W., Wang, T., Zhang, S., Yang, Y., Deng, F., Zhang, Q., Chen, X., Yang, Y., Sun, X., Chen, H., Tao, Y. J., Zou, Z., & Jin, M.
Affiliations
  • Huazhong Agricultural University (CN)
  • Rice University (US)
Corresponding author
  • Zou, Zhong
  • Jin, Meilin
ORCID
Venue
EBioMedicine
Publisher
Elsevier BV
Published
2021-05
Volume
67
Pages
103381
ISSN
2352-3964 (ISSN-L)
DOI
10.1016/j.ebiom.2021.103381
PMC
PMC8118724
OpenAlex
W3162133013
Cited by
119
References
52
Citations by year
2026: 5 · 2025: 8 · 2024: 20 · 2023: 17 · 2022: 55 · 2021: 14
FWCI
8.55
Type
journal article
Language
en
Open access
Licence
Locations
  • EBioMedicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Rice Research Repository (Rice University) (submittedVersion, cc-by-nc-nd)
Funders
  • Welch Foundation (C-1565)
  • Chinese Academy of Sciences
  • Hubei Province Department of Science and Technology (2020FCA046)
  • State Key Laboratory of Virology
  • National Key Research and Development Program of China (2020YFC0845600)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS-CoV-2, spike protein, receptor binding domain, mouse-adapted virus, ACE2 receptor, receptor binding affinity, interstitial lung disease, TLR7/8 agonist, resiquimod, antiviral activity, adaptive mutation
MeSH terms
Whole Genome Sequencing, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Adaptation, Physiological, Animals, Binding Sites, Chlorocebus aethiops, Disease Models, Animal, Female, Humans, Imidazoles, Mice, Inbred BALB C, Serial Passage, Vero Cells, Virus Replication, Caco-2 Cells, Amino Acid Substitution, Mice, High-Throughput Nucleotide Sequencing, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review